CClinicalTrials.gg
RecruitingNCT05307952AuDiETUpdated Jul 5, 2023

Auditory Diagnostics and Error-based Treatment

An interventional study of Tone Audiometry and Spectrotemporal Assessment in Deafness, Bilateral, Deafness Neurosensory and Deafness Permanent, sponsored by Radboud University Medical Center. Recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-05.

Sponsored by Radboud University Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2023, 3 years ago, but the record still lists the study as recruiting.
  • Started May 2022; still recruiting 4 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The main objective of this study is to assess the effectiveness of an integrated program of fitting and training interventions aimed at reducing unexpected variability and addressing the specific error patterns of each recipient.

The participants will undergo 1 visit lasting approximately 2 hours at the Radboud university medical center's ENT department, where they will undergo a series of diagnostic tests. Some of the participants will also be asked to self-administer additional tests using a Windows tablet.

Based on the outcomes of speech recognition tests in quiet at the first visit, the participants will be called for follow-up interventions concerning both the fitting of their CI and personalized auditory training based on their personal error patterns. These interventions will take place over the course of approximately 5 months and will be made up of three follow-up visits and a period of self-administered training through a mobile application on a tablet.

One final follow-up visit will check whether any changes from the interventions are retained after four weeks.

02

Conditions studied

  • Deafness, Bilateral
  • Deafness Neurosensory
  • Deafness Permanent

Keywords

  • Cochlear Implant
  • Speech Perception
  • Hearing
  • Speech
  • Prosthesis Fitting
  • Rehabilitation
03

In context

Deafness

609 studies on the registry are indexed under Deafness; 111 are open to participants now.

This study's planned enrollment of 25 is below the median of 40 across 411 interventional studies indexed under Deafness.

Browse Deafness studies →

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult (over 18 years old at the time of inclusion )
  • Post-lingually deafened (the subject had a good mastery of spoken language before onset of deafness)
  • Native Dutch speaker
  • Implanted, either unilaterally or bilaterally, with a Cochlear Implant manufactured by Cochlear Ltd (i.e., a Nucleus ® implant).
  • Implanted with one of the following implants: CI422, CI512, CI522, CI532, CI24M, CI24R, CI24RE.
  • Implanted for at least 12 months.

Exclusion criteria

Exclusion Criteria:

  • Known abnormally formed cochlea
  • Known pre-implantation ossification of the cochlea
  • Severe cognitive disorders affecting their ability to understand spoken language
  • Intense facial nerve stimulation
  • Unaddressed electrode tip foldover
  • More than 4 electrodes deactivated because of malfunction (open/short circuit) or lack of response
  • Additional illnesses or handicaps that could impact ability to participate in study, at the clinician's discretion.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Fitting and Training Intervention

    All participants will undergo the full set of diagnostic visits and both Fitting and Training interventions. The Fitting Intervention is an adjustment of their processors' MAPs based on their error pattern. The Training Intervention is a personalized training via an app focusing on their most frequent errors.

    Diagnostic Test: Tone Audiometry · Diagnostic Test: Spectrotemporal Assessment · Diagnostic Test: Phoneme and Speech Perception · Diagnostic Test: Digit Triplet Test · Other: Personalized fitting · Behavioral: Personalized training

Interventions

  • Diagnostic testTone Audiometry

    Evaluation of the participants' audiometrical thresholds

  • Diagnostic testSpectrotemporal Assessment

    Evaluation of the participants' promptness in detecting a modulation of a harmonic complex

  • Diagnostic testPhoneme and Speech Perception

    Evaluation of the participants' understanding of phonemes and short words, both in quiet and in noise

  • Diagnostic testDigit Triplet Test

    Evaluation of the participants' ability to discern speech in noise

  • OtherPersonalized fitting

    Adjustment of the parameters of the participants' cochlear implants aimed at improving their speech perception

  • BehavioralPersonalized training

    Self-administered training exercises focused on the speech components the participants are experiencing difficulties into

06

What researchers measure

Primary outcomes

  1. Change in Percent Speech Recognition

    Given a list of CNC words, this score measures the percentage of correctly identified words.

    Time frame: Weeks 1, 10, 14, 18

Secondary outcomes

  1. Change in Distance-based Accuracy Score

    Speech Recognition accuracy score based on phoneme distance, such that mistaking a phoneme for a similar one such as mistaking /k/ for /g/ gives a lower penalty than mistaking a phoneme for a very different one.

    Time frame: Weeks 1, 10, 14, 18

  2. Change in Error Dispersion

    Mathematical quantification of how much the errors made by the subjects are spread between stimuli and responses

    Time frame: Weeks 1, 10, 14, 18

07

Study locations

1 of 1 sites recruiting
  • Radboud university medical center
    Nijmegen, Gelderland 6500, Netherlands
    • Wendy Huinck, PhD · Contact · Wendy.Huinck@radboudumc.nl · +31243613506
    • Wendy Huinck, PhD · Principal investigator
    • Enrico Migliorini · Sub investigator
    • Nikki Tromp · Sub investigator
    • Jan-Willem Wasmann · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — There is no plan to make IPD available to any researchers not involved in the project

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05307952
Lead sponsor
Radboud University Medical Center
Collaborators
Cochlear
Responsible party
Sponsor
First posted
Apr 1, 2022
Start date
May 30, 2022
Primary completion
Oct 2023 (estimated)
Completion
Dec 2024 (estimated)
Last update
Jul 5, 2023

Study contacts

Wendy Huinck, PhD
Contact
Wendy.Huinck@radboudumc.nl
+31243613506
Wendy Huinck, PhD
principal investigator · Radboud University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion